<DOC>
	<DOCNO>NCT00630929</DOCNO>
	<brief_summary>To compare efficacy safety celecoxib versus ibuprofen subject osteoarthritis ( OA ) knee .</brief_summary>
	<brief_title>Efficacy Safety Celecoxib Versus Ibuprofen Treatment Osteoarthritis Knee ( Europe )</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Inclusion criterion : Aged &gt; =40 year old Diagnosed OA knee accord American College Rheumatology OA flare state baseline visit Functional capacity class IIII Exclusion criterion : Inflammatory arthritis gout pseudogout acute flare within past 2 year ( subject fibrositis fibromyalgia exclude ) Acute joint trauma index joint within past 3 month active symptom Score &gt; =20 PHQ9 score &gt; =1 PHQ9 item Use mobility assist device &lt; 6 week use walker</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>